Assignee
KELONIA THERAPEUTICS INC
US·5 granted patents·3 pending applications·7 citations·filing 2022–2025
Top patents by PatentIndex Score
8 records- 0194US12312593B2Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·3 cites·10 claims
- 0292US12269882B1Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·3 cites·30 claims
- 0390US12440564B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·1 cites·25 claims
- 0483US12403194B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·25 claims
- 0580US2026007748A1Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0674US2025277238A1Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0771US12435140B2Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2025·Granted Oct 7, 2025·0 cites·30 claims
- 0870US2024218390A1Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →